586 related articles for article (PubMed ID: 17600122)
1. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
3. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
4. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
[TBL] [Abstract][Full Text] [Related]
5. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.
Fickert P; Fuchsbichler A; Marschall HU; Wagner M; Zollner G; Krause R; Zatloukal K; Jaeschke H; Denk H; Trauner M
Am J Pathol; 2006 Feb; 168(2):410-22. PubMed ID: 16436656
[TBL] [Abstract][Full Text] [Related]
6. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Fickert P; Thueringer A; Moustafa T; Silbert D; Gumhold J; Tsybrovskyy O; Lebofsky M; Jaeschke H; Denk H; Trauner M
Lab Invest; 2010 Jun; 90(6):844-52. PubMed ID: 20368698
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
9. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
Pose E; Sancho-Bru P; Coll M
Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
[TBL] [Abstract][Full Text] [Related]
10. Xenobiotic-induced liver injury and fibrosis.
Österreicher CH; Trauner M
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
[TBL] [Abstract][Full Text] [Related]
12. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
[TBL] [Abstract][Full Text] [Related]
13. Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis.
Wen M; Liu Y; Chen R; He P; Wu F; Li R; Lin Y
Phytother Res; 2021 Jul; 35(7):3799-3811. PubMed ID: 33763888
[TBL] [Abstract][Full Text] [Related]
14. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
[TBL] [Abstract][Full Text] [Related]
15. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis.
Miyao M; Ozeki M; Abiru H; Manabe S; Kotani H; Tsuruyama T; Tamaki K
Dig Liver Dis; 2013 Mar; 45(3):216-25. PubMed ID: 23107486
[TBL] [Abstract][Full Text] [Related]
16. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
17. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
19. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
